Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer

Genes Chromosomes and Cancer

Volumn 48, Issue 7, 2009, Pages 544-551

  Koski, Taru A ^a   Lehtonen, Heli J ^a   Jee, Kowan J ^a   Ninomiya, Shinsuke ^a   Joosse, Simon A ^b   Vahteristo, Pia ^a   Kiuru, Maija ^a   Karhu, Auli ^a   Sammalkorpi, Heli ^a   Vanharanta, Sakari ^a   Lehtonen, Rainer ^a   Edgren, Henrik ^a,c   Nederlof, Petra M ^b   Hietala, Marja ^d   Aittomäki, Kristiina ^a,e   Herva, Riitta ^f   Knuutila, Sakari ^a   Aaltonen, Lauri A ^a   Launonen, Virpi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY OF TURKU   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FUMARATE HYDRATASE; PARAFFIN; SCATTER FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CHROMOSOME 13Q; CHROMOSOME 14; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 2; CHROMOSOME 7; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENE NUMBER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CANCER; LEIOMYOMATOSIS; MALE; PRIORITY JOURNAL; X CHROMOSOME;

ADULT; AGED; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE DELETION; GENE DOSAGE; HUMANS; KIDNEY NEOPLASMS; LEIOMYOMATOSIS; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL;

EID: 67449088342     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20663     Document Type: Article

References (31)

1. Alam NA, Barclay E, Rowan AJ, Tyrer JP, Calonje E, Manek S, Kelsell D, Leigh I, Olpin S, Tomlinson IP. 2005. Clinical features of multiple cutaneous and uterine leiomyomatosis: An underdiagnosed tumor syndrome. Arch Dermatol 141:199-206. (Pubitemid 40216262)
2. Alam NA, Rowan AJ, Wortham NC, Pollard PJ, Mitchell M, Tyrer JP, Barclay E, Calonje E, Manek S, Adams SJ, Bowers PW, Burrows NP, Charles-Holmes R, Cook LJ, Daly BM, Ford GP, Fuller LC, Hadfield-Jones SE, Hardwick N, Highet AS, Keefe M, MacDonald-Hull SP, Potts ED, Crone M, Wilkinson S, Camacho-Martinez F, Jablonska S, Ratnavel R, MacDonald A, Mann RJ, Grice K, Guillet G, Lewis-Jones MS, McGrath H, Seukeran DC, Morrison PJ, Fleming S, Rahman S, Kelsell D, Leigh I, Olpin S, Tomlinson IP. 2003. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12:1241-1252. (Pubitemid 36722604)
3. Badeloe S, van Geel M, van Steensel MA, Bastida J, Ferrando J, Steijlen PM, Frank J, Poblete-Gutierrez P. 2006. Diffuse and segmental variants of cutaneous leiomyomatosis: Novel mutations in the fumarate hydratase gene and review of the literature. Exp Dermatol 15:735-741. (Pubitemid 44145243)
4. Blons H, Laccourreye O, Houllier AM, Carnot F, Brasnu D, Beaune P, Zucman-Rossi J, Laurent-Puig P. 2002. Delineation and candidate gene mutation screening of the 18q22 minimal region of deletion in head and neck squamous cell carcinoma. Oncogene 21:5016-5023. (Pubitemid 34888348)
5. Chan I, Wong T, Martinez-Mir A, Christiano AM, McGrath JA. 2005. Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer. Clin Exp Dermatol 30:75-78. (Pubitemid 40188325)
6. Chuang GS, Martinez-Mir A, Engler DE, Gmyrek RF, Zlotogorski A, Christiano AM. 2006. Multiple cutaneous and uterine leiomyomata resulting from missense mutations in the fumarate hydratase gene. Clin Exp Dermatol 31:118-121.
7. Delahunt B and Eble JN. 1997. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10:537-544. (Pubitemid 27293491)
8. Furge KA, Chen J, Koeman J, Swiatek P, Dykema K, Lucin K, Kahnoski R, Yang XJ, Teh BT. 2007. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Res 67:3171-3176. (Pubitemid 46724854)
9. Grubb RL, III, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, Torres-Cabala C, Glenn GM, Choyke P, Merino MJ, Zbar B, Pinto PA, Srinivasan R, Coleman JA, Linehan WM. 2007. Hereditary leiomyomatosis and renal cell cancer: A syndrome associated with an aggressive form of inherited renal cancer. J Urol 177:2074-2079. (Pubitemid 46735952)
10. Gunawan B, von Heydebreck A, Fritsch T, Huber W, Ringert RH, Jakse G, Fuzesi L. 2003. Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: Evidence for a cytogenetic evolution of type 2 from type 1 tumors. Cancer Res 63:6200-6205. (Pubitemid 37255164)
11. Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, Ratcliffe PJ, Linehan WM, Neckers L. 2005. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability. Cancer Cell 8:143-153.
12. Jiang F, Richter J, Schraml P, Bubendorf L, Gasser T, Sauter G, Mihatsch MJ, Moch H. 1998. Chromosomal imbalances in papillary renal cell carcinoma: Genetic differences between histological subtypes. Am J Pathol 153:1467-1473. (Pubitemid 28509903)
13. Kovacs G. 1993a. Molecular cytogenetics of renal cell tumors. Adv Cancer Res 62:89-124. (Pubitemid 23361850)
14. Kovacs G. 1993b. Molecular differential pathology of renal cell tumours. Histopathology 22:1-8. (Pubitemid 23043987)
15. Kovacs G. 1999. Molecular genetics and diagnosis of renal cell tumors. Urologe A 38:433-441. (Pubitemid 29453145)
16. Kovacs G, Fuzesi L, Emanual A, Kung HF. 1991. Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer 3:249-255.
17. Launonen V, Vierimaa O, Kiuru M, Isola J, Roth S, Pukkala E, Sistonen P, Herva R, Aaltonen LA. 2001. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 98:3387-3392.
18. Lehtonen HJ, Blanco I, Piulats JM, Herva R, Launonen V, Aaltonen LA. 2007. Conventional renal cancer in a patient with fumarate hydratase mutation. Hum Pathol 38:793-796.
19. Lehtonen HJ, Kiuru M, Ylisaukko-Oja SK, Salovaara R, Herva R, Koivisto PA, Vierimaa O, Aittomaki K, Pukkala E, Launonen V, Aaltonen LA. 2006. Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet 43:523-526.
20. Niu J, Azfer A, Zhelyabovska O, Fatma S, Kolattukudy PE. 2008. Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP). J Biol Chem 283:14542-14551.
21. Pollard PJ, Briere JJ, Alam NA, Barwell J, Barclay E, Wortham NC, Hunt T, Mitchell M, Olpin S, Moat SJ, Hargreaves IP, Heales SJ, Chung YL, Griffiths JR, Dalgleish A, McGrath JA, Gleeson MJ, Hodgson SV, Poulsom R, Rustin P, Tomlinson IP. 2005. Accumulation of Krebs cycle intermediates and over- expression of HIFlalpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14:2231-2239. (Pubitemid 41418022)
22. Prat E, Bernues M, Del Rey J, Camps J, Ponsa I, Algaba F, Egozcue J, Caballin MR, Gelabert A, Miro R. 2006. Common pattern of unusual chromosome abnormalities in hereditary papillary renal carcinoma. Cancer Genet Cytogenet 164:142-147.
23. Refae MA, Wong N, Patenaude F, Begin LR, Foulkes WD. 2007. Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma. Nat Clin Pract Oncol 4:256-261. (Pubitemid 46510535)
24. Sanders ME, Mick R, Tomaszewski JE, Barr FG. 2002. Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma. Am J Pathol 161:997-1005. (Pubitemid 34988387)
25. Scheinin I, Myllykangas S, Borze I, Bohling T, Knuutila S, Saharinen J. 2008. CanGEM: Mining gene copy number changes in cancer. Nucleic Acids Res 36:830-835.
26. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJ, Walther MM, Tsui LC, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Storkel S, Lerman MI, Linehan WM, Zbar B. 1997. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68-73.
27. Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, Bevan S, Barker K, Hearle N, Houlston RS, Kiuru M, Lehtonen R, Karhu A, Vilkki S, Laiho P, Eklund C, Vierimaa O, Aittomaki K, Hietala M, Sistonen P, Paetau A, Salovaara R, Herva R, Launonen V, Aaltonen LA, Multiple Leiomyoma C. 2002. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406-410.
28. Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML, Stewart L, Duray P, Tourre O, Sharma N, Choyke P, Stratton P, Merino M, Walther MM, Linehan WM, Schmidt LS, Zbar B. 2003. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73:95-106. (Pubitemid 36793783)
29. Trusolino L, Comoglio PM. 2002. Scatter-factor and semaphorin receptors: Cell signalling for invasive growth. Nature Rev Cancer 2:289-300. (Pubitemid 37328782)
30. Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P, Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan WM, Toro JR. 2006. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43:18-27. (Pubitemid 43099991)
31. Yang XJ, Tan MH, Kim HL, Ditlev JA, Betten MW, Png CE, Kort EJ, Futami K, Furge KA, Takahashi M, Kanayama HO, Tan PH, Teh BS, Luan C, Wang K, Pins M, Tretiakova M, Anema J, Kahnoski R, Nicol T, Stadler W, Vogelzang NG, Amato R, Seligson D, Figlin R, Belldegrun A, Rogers CG, Teh BT. 2005. A molecular classification of papillary renal cell carcinoma. Cancer Res 65:5628-5637. (Pubitemid 40911163)